ArticleJournal of medical physics
Feasibility of Magnetic Resonance-based Synthetic Computed Tomography for Proton Dose Calculation in Prostate Cancer.
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This study evaluates the feasibility of deep learning-generated synthetic computed tomography (sCT) for proton dose calculation. Materials and Methods: The sCT images were generated from T2-weighted magnetic resonance imaging (MRI) of 10 retrospectively collected prostate cancer patients using MRI Planner (Spectronic Medical, Sweden). The sCT images were compared with CT images to assess image quality, proton range, and dosimetric evaluation. Image quality was evaluated using mean Hounsfield unit (HU) difference, mean absolute error (MAE), and mean error. Geometric agreement between CT and sCT images was measured using the dice similarity coefficient (DSC). Ground truth CT images were employed to generate single-field uniform dose (SFUD) and intensity-modulated proton therapy plans for each patient. The proton range shift (RS) between CT and sCT images was calculated at the central 80% distal dose falloff in each SFUD plan. Dosimetric evaluations were performed using dose-volume histogram comparison and gamma index analysis. Results: The mean MAE values for the body, bone, and soft tissue were 43.42 ± 3.96, 118.40 ± 9.70, and 33.90 ± 4.04 HU, respectively. DSC values revealed good geometric agreement between sCT and CT images. All RS values fell within clinically acceptable criteria, with a relative RS ranging from 0.02%-0.67%. The relative dose differences for all clinical target volume metrics were less than ±1.0%, and gamma pass rates exceeded 90% at 3%/3 mm, 3%/2 mm, and 2%/2 mm criteria. Conclusion: sCT images generated by MRI Planner were feasibly used for proton dose calculation in prostate cancer and could potentially be used for implementing MRI-only proton therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.